CMOS Study

Welcome to the CMOS Study

The CMOS study, is Australia’s largest medicinal Cannabis study. The CMOS study has a target of 20,000 patients over a 5 year period. 

This study aims to collect important real-world data about safety and efficacy of medicinal cannabis products in the treatment of refractory indications, as well as data on effective dosage and effects of medicinal cannabis treatment on concomitant medication use. 

For more study specific information click below